Possible Tacrolimus-Related Neuropsychiatric Symptoms: One Year After Allogeneic Hematopoietic Cell Transplantation: A Case Report

Tacrolimus is a calcineurin inhibitor (CNI), an immunosuppressive agent used to prevent graft versus host disease following allogeneic hematopoietic cell transplantation (HCT). Side-effects of tacrolimus treatment include neuropsychiatric symptoms, for example, affective disturbances, psychosis, and...

Descripción completa

Detalles Bibliográficos
Autores principales: Løhde, Linda W, Bentzon, Adrian, Kornblit, Brian T, Roos, Peter, Fink-Jensen, Anders
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2022
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8941686/
https://www.ncbi.nlm.nih.gov/pubmed/35342316
http://dx.doi.org/10.1177/11795476221087053

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8941686/
https://www.ncbi.nlm.nih.gov/pubmed/35342316
http://dx.doi.org/10.1177/11795476221087053

Ejemplares similares